Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

Share Price Information for Mandarin In.sg (MDO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.06
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.06
MDO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

10 Nov 2022 09:42

RNS Number : 9939F
Mandarin Oriental International Ltd
10 November 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

10th November 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2022.

 

The return of normal travel conditions in most of the world in early 2022 saw the Group record net underlying profits (unaudited) in the second quarter, and this progress continued in the third quarter.

 

In the Group's owned hotels, improvements in occupancy and high rates resulted in a stronger performance in the third quarter. This drove increased profitability compared to the second quarter, particularly in Paris and Munich. Two of the Group's key profit-generating hotels, in Hong Kong and Tokyo, however, remained subject to stringent travel restrictions throughout the third quarter, which significantly impacted operating performance. The hotels in Bangkok and Singapore continued their recovery following the removal of travel barriers.

 

The performance of the management business was strong in the third quarter and it recorded a significant improvement in profitability compared to the second quarter. Of particular note were the contributions made by a number of the Group's Mediterranean and Middle Eastern properties.

 

As a result of the improved trading conditions and Mandarin Oriental's expanded portfolio of hotels and residences, the Group recorded its highest quarterly EBITDA since 2019. Both the owned hotels and the management business delivered higher EBITDA than in the second quarter of 2022.

 

In September 2022, the Group opened Mandarin Oriental Palace, Luzern, its second hotel in Switzerland, and its standalone residences project in Barcelona. Recently, the Group announced a new hotel in Tianfu, the new business district of Chengdu, further expanding its presence in China. On 8th September 2022, the Group completed the sale of Mandarin Oriental, Washington D.C., for US$139 million. As a result, the Group has recognised a post-tax, non-trading gain in the third quarter of US$47 million.

 

Following the disposal, net debt at 30th September 2022 reduced to US$385 million (US$519 million at 30th June 2022), and the Group held US$267 million of cash reserves and US$472 million in available, committed debt facilities. Gearing was 8% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKBLBFLFLXFBK
Date   Source Headline
24th Dec 20157:56 amRNSDirector/PDMR Shareholding
23rd Dec 201510:27 amRNSDirector/PDMR Shareholding
30th Nov 20159:35 amRNSDirector Declaration
26th Nov 20159:18 amRNSDirectorate Change
26th Nov 20159:15 amRNSJames Riley to Succeed Edouard Ettedgui as GroupCE
26th Nov 20159:10 amRNSDirectorate Change
4th Nov 20159:16 amRNSInterim Management Statement
2nd Oct 201510:47 amRNSDirector/PDMR Shareholding
30th Sep 201511:04 amRNSDirector/PDMR Shareholding
30th Sep 201510:14 amRNSDividend
30th Sep 201510:12 amRNSTotal Voting Rights
25th Sep 201511:09 amRNSDirector/PDMR Shareholding
25th Sep 201510:15 amRNSBlocklisting Interim Review
23rd Sep 201510:54 amRNSDirector/PDMR Shareholding
3rd Aug 201511:20 amRNSDirector Declaration
30th Jul 201510:16 amRNSDirectorate Change
30th Jul 201510:07 amRNSHalf Yearly Results - 6 months ended 30 June 2015
2nd Jul 201510:19 amRNSNotice of 2015 Half-Yearly Results
30th Jun 201510:15 amRNSTotal Voting Rights
9th Jun 201511:40 amRNSDirector/PDMR Shareholding
29th May 201510:51 amRNSTotal Voting Rights
22nd May 20157:00 amRNSMandarin Oriental JV to Acquire Hotel Ritz, Madrid
14th May 20158:39 amRNSAdditional Listing
6th May 20152:09 pmRNSNon-Routine Resolutions submitted via NSM
6th May 20151:59 pmRNSResult of AGM
30th Apr 201511:33 amRNSTotal Voting Rights
29th Apr 201510:46 amRNSDividend
9th Apr 20151:24 pmRNSDirector/PDMR Shareholding
9th Apr 201510:30 amRNSAnnual Financial Report
8th Apr 201510:16 amRNSTotal Voting Rights
7th Apr 20155:01 pmRNSResults of 1 for 4 Rights Issue
7th Apr 201510:13 amRNSDirector/PDMR Shareholding
30th Mar 201510:32 amRNSDirector Declaration
25th Mar 20159:18 amRNSDirector/PDMR Shareholding
25th Mar 20159:16 amRNSBlocklisting Interim Review
20th Mar 20159:15 amRNSDirector/PDMR Shareholding
16th Mar 20158:29 amRNSAdmission to Trading
12th Mar 20159:42 amRNSPublication of Prospectus
5th Mar 201510:39 amRNSDirector Declaration
5th Mar 20159:20 amRNS1 FOR 4 RIGHTS ISSUE TO RAISE US$316 MILLION
5th Mar 20159:16 amRNS2014 Preliminary Announcement of Results
2nd Feb 20159:24 amRNSNotice of 2014 Final Results
31st Dec 20147:28 amRNSTotal Voting Rights
2nd Dec 201410:14 amRNSDirector/PDMR Shareholding
5th Nov 201410:08 amRNSInterim Management Statement
30th Sep 201410:10 amRNSDividend
30th Sep 201410:10 amRNSTotal Voting Rights
25th Sep 201410:07 amRNSBlocklisting Interim Review
31st Jul 201410:08 amRNSTotal Voting Rights
31st Jul 201410:06 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.